New Delhi, April 27 (IANS) India’s major drugmaker Sun Pharmaceutical Industries on Monday announced that it will acquire New York-listed Organon & Co in an all-cash deal valued at $11.75 billion, its biggest overseas acquisition to date.Under the agreement, the pharmaceutical firm will acquire 100 per cent of Organon’s outstanding shares at $14 per share, translating into an enterprise valuation of $11.75 billion and an equity value of around $3.99 billion, the company said in an exchan…
Trending
- Mother Promise 2026 Movie Review: This Kannada Gangster Comedy Is Pure Absurd Fun
- Love Oh Love 2026 Movie Review: A Breezy, Feel-Good Romantic Entertainer That Flips the Script on Modern Love
- Lenin 2026 Movie Review: Akhil Akkineni’s Career-Best Rural Drama Draws Power From the Mahabharata
- Idhayam Murali Review: Atharvaa Shines In A Breezy But Overstretched Ode To Unspoken Love
- Ikka Movie Review: Sunny Deol and Akshaye Khanna Deliver a Gripping Courtroom Battle Rooted in Family and Conviction
- Dhamaal 4 Movie Review: Ajay Devgn, Riteish Deshmukh & Arshad Warsi Prove The Madness Never Gets Old!
- Harry Potter Bollywood Cast Goes Viral: Real or Fake? Full List Inside
- Trendy Tunics for Summer – Breezy Tunic Tops Styled for the Heat